LINC01132 and hepatocellular carcinoma: LINC01132 has been identified as a novel oncogenic lncRNA, with its expression significantly higher in HCC tumor tissues compared to normal tissues, correlating with poor survival rates in patients, primarily driven by copy number amplification.